Skip to main content
Tech.euFundingExplorerBeta

Inositec

Exited

Inositec is a biotech company that develops a treatment for soft tissue calcification disorders.

Inositec is tracked in the Tech.eu funding database. Based in Zurich, Switzerland; active in Healthtech. Acquired by Vifor Pharma in 2021. Data as of Nov 2026.

Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—

Funding rounds

0 rounds
No funding rounds recorded.

Exit

Type
acquisition
Date
Nov 2021
Value
€19M
Acquiror
Vifor Pharma (Switzerland)

Related news

Similar companies

same sector, similar size

Global coverage: FundingData